Clinical Trials and COVID-19: Shaping of Agenda, Policies and Practices for a Transparent Future

The outbreak of the COVID-19 pandemic, and the rapid development of associated vaccines and therapeutics, has driven a renewed interest and attention for clinical trials. In doing so, it has highlighted the importance of the integrity of the whole process. However, this should not take the focus away from other structural elements in the management of clinical trials, namely the need for greater transparency and accessibility to clinical data.

In April 2022, we hosted an online roundtable to share and gather feedback on a pending joint publication with TranspariMED that contributes to ongoing discussions on clinical trial transparency at the World Health Organization, European Union, and at national level.